S&P 500   2,994.30 (+0.15%)
DOW   26,989.06 (-0.05%)
QQQ   193.09 (+0.03%)
AAPL   233.95 (-0.18%)
FB   189.55 (+0.00%)
MSFT   139.23 (-0.84%)
GOOGL   1,251.95 (+0.72%)
AMZN   1,788.00 (+0.59%)
CGC   20.21 (+2.43%)
NVDA   192.86 (-0.70%)
MU   45.42 (+0.58%)
BABA   176.38 (-0.42%)
GE   9.08 (+1.91%)
TSLA   260.99 (+0.48%)
AMD   30.97 (+0.52%)
F   9.11 (+0.44%)
ACB   3.79 (+4.99%)
NFLX   297.91 (+4.06%)
GILD   65.06 (-0.44%)
DIS   132.72 (+1.42%)
S&P 500   2,994.30 (+0.15%)
DOW   26,989.06 (-0.05%)
QQQ   193.09 (+0.03%)
AAPL   233.95 (-0.18%)
FB   189.55 (+0.00%)
MSFT   139.23 (-0.84%)
GOOGL   1,251.95 (+0.72%)
AMZN   1,788.00 (+0.59%)
CGC   20.21 (+2.43%)
NVDA   192.86 (-0.70%)
MU   45.42 (+0.58%)
BABA   176.38 (-0.42%)
GE   9.08 (+1.91%)
TSLA   260.99 (+0.48%)
AMD   30.97 (+0.52%)
F   9.11 (+0.44%)
ACB   3.79 (+4.99%)
NFLX   297.91 (+4.06%)
GILD   65.06 (-0.44%)
DIS   132.72 (+1.42%)
Log in

Viking Therapeutics News Headlines (NASDAQ:VKTX)

$6.68
+0.10 (+1.52 %)
(As of 10/17/2019 12:12 PM ET)
Today's Range
$6.58
Now: $6.68
$6.74
50-Day Range
$6.33
MA: $6.93
$7.64
52-Week Range
$6.15
Now: $6.68
$15.69
Volume29,424 shs
Average Volume1.55 million shs
Market Capitalization$482.36 million
P/E RatioN/A
Dividend YieldN/A
Beta2.31

Headlines

Viking Therapeutics (NASDAQ VKTX) News Headlines

Source:
DateHeadline
Zacks: Analysts Anticipate Viking Therapeutics Inc (NASDAQ:VKTX) to Announce -$0.13 Earnings Per ShareZacks: Analysts Anticipate Viking Therapeutics Inc (NASDAQ:VKTX) to Announce -$0.13 Earnings Per Share
www.americanbankingnews.com - October 17 at 5:29 AM
Viking Therapeutics Inc (NASDAQ:VKTX) Sees Significant Drop in Short InterestViking Therapeutics Inc (NASDAQ:VKTX) Sees Significant Drop in Short Interest
www.americanbankingnews.com - October 16 at 6:08 PM
Viking Therapeutics Inc (NASDAQ:VKTX) Receives Consensus Rating of "Buy" from AnalystsViking Therapeutics Inc (NASDAQ:VKTX) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - October 8 at 3:31 AM
Viking Therapeutics to Present at 2019 Cantor Global Healthcare ConferenceViking Therapeutics to Present at 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 25 at 8:27 AM
 Analysts Expect Viking Therapeutics Inc (NASDAQ:VKTX) Will Post Earnings of -$0.13 Per Share Analysts Expect Viking Therapeutics Inc (NASDAQ:VKTX) Will Post Earnings of -$0.13 Per Share
www.americanbankingnews.com - September 24 at 10:45 AM
We Think Viking Therapeutics (NASDAQ:VKTX) Can Easily Afford To Drive Business GrowthWe Think Viking Therapeutics (NASDAQ:VKTX) Can Easily Afford To Drive Business Growth
finance.yahoo.com - September 23 at 3:47 PM
Viking Therapeutics: A Potential NASH BlockbusterViking Therapeutics: A Potential NASH Blockbuster
seekingalpha.com - August 13 at 11:47 PM
Viking Therapeutics Inc (VKTX) Q2 2019 Earnings Call TranscriptViking Therapeutics Inc (VKTX) Q2 2019 Earnings Call Transcript
www.fool.com - August 6 at 2:16 AM
Where Will Viking Therapeutics Be in 1 Year?Where Will Viking Therapeutics Be in 1 Year?
www.fool.com - August 5 at 11:39 PM
Edited Transcript of VKTX earnings conference call or presentation 1-Aug-19 8:30pm GMTEdited Transcript of VKTX earnings conference call or presentation 1-Aug-19 8:30pm GMT
finance.yahoo.com - August 3 at 8:38 AM
VKTX: Awaiting Feedback from FDA regarding pre-IND submission; Phase 2b trial in NASH expected to initiate 2H19…VKTX: Awaiting Feedback from FDA regarding pre-IND submission; Phase 2b trial in NASH expected to initiate 2H19…
finance.yahoo.com - August 3 at 8:38 AM
Viking Therapeutics (VKTX) CEO Brian Lian on Q2 2019 Results - Earnings Call TranscriptViking Therapeutics' (VKTX) CEO Brian Lian on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 2 at 12:45 AM
Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateViking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 2 at 12:45 AM
Options Traders Load Up On VKTX Calls Ahead of EarningsOptions Traders Load Up On VKTX Calls Ahead of Earnings
finance.yahoo.com - July 31 at 11:54 PM
Viking Therapeutics to Report Financial Results for Second Quarter 2019 on August 1, 2019Viking Therapeutics to Report Financial Results for Second Quarter 2019 on August 1, 2019
finance.yahoo.com - July 26 at 8:47 AM
Oppenheimer likes Millendo Therapeutics in premarket analyst actionOppenheimer likes Millendo Therapeutics in premarket analyst action
seekingalpha.com - July 16 at 8:43 AM
Viking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of DirectorsViking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of Directors
www.marketwatch.com - July 2 at 6:39 PM
Here’s What Hedge Funds Think About Viking Therapeutics, Inc. (VKTX)Here’s What Hedge Funds Think About Viking Therapeutics, Inc. (VKTX)
finance.yahoo.com - June 20 at 7:50 PM
How Viking Therapeutics Is PositionedHow Viking Therapeutics Is Positioned
finance.yahoo.com - June 15 at 12:22 AM
Have Insiders Been Buying Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares?Have Insiders Been Buying Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares?
finance.yahoo.com - May 14 at 7:59 PM
Were Hedge Funds Right About Dumping Viking Therapeutics, Inc. (VKTX) ?Were Hedge Funds Right About Dumping Viking Therapeutics, Inc. (VKTX) ?
finance.yahoo.com - May 9 at 7:44 PM
Edited Transcript of VKTX earnings conference call or presentation 2-May-19 8:30pm GMTEdited Transcript of VKTX earnings conference call or presentation 2-May-19 8:30pm GMT
finance.yahoo.com - May 3 at 7:14 PM
VKTX: Pre-IND Meeting with FDA in Summer 2019; Phase 2b NASH Trial to Initiate 2H19…VKTX: Pre-IND Meeting with FDA in Summer 2019; Phase 2b NASH Trial to Initiate 2H19…
finance.yahoo.com - May 3 at 7:14 PM
Viking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q1 2019 Results - Earnings Call TranscriptViking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 3 at 8:28 AM
Viking Therapeutics Inc (VKTX) Q1 2019 Earnings Call TranscriptViking Therapeutics Inc (VKTX) Q1 2019 Earnings Call Transcript
www.fool.com - May 2 at 9:15 PM
Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate UpdateViking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - May 2 at 7:59 PM
2 Reasons Gilead Sciences' NASH Program Could Bounce Back2 Reasons Gilead Sciences' NASH Program Could Bounce Back
finance.yahoo.com - April 27 at 8:24 AM
Viking Therapeutics to Report Financial Results for First Quarter 2019 on May 2, 2019Viking Therapeutics to Report Financial Results for First Quarter 2019 on May 2, 2019
finance.yahoo.com - April 25 at 8:18 AM
VKTX: VK2809 5 mg Data Presented at EASL…VKTX: VK2809 5 mg Data Presented at EASL…
finance.yahoo.com - April 12 at 8:29 PM
Viking Therapeutics Jumps as New Liver Drug Gets Positive ResultsViking Therapeutics Jumps as New Liver Drug Gets Positive Results
finance.yahoo.com - April 11 at 7:43 PM
Viking ahead 7% premarket on new VK2809 dataViking ahead 7% premarket on new VK2809 data
seekingalpha.com - April 11 at 9:15 AM
Viking Therapeutics Presents New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress™ 2019Viking Therapeutics Presents New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress™ 2019
finance.yahoo.com - April 11 at 9:15 AM
Heres Why Investors Are Betting Against These 2 Biotech StocksHere's Why Investors Are Betting Against These 2 Biotech Stocks
www.fool.com - April 6 at 8:23 AM
Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress™ 2019Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress™ 2019
finance.yahoo.com - April 4 at 8:27 AM
Viking Therapeutics up 6% premarket; Leerink bullishViking Therapeutics up 6% premarket; Leerink bullish
seekingalpha.com - March 29 at 7:38 PM
Heres What Pushed Viking Therapeutics Higher on FridayHere's What Pushed Viking Therapeutics Higher on Friday
finance.yahoo.com - March 29 at 7:38 PM
The Best Approach to Trading LyftThe Best Approach to Trading Lyft
finance.yahoo.com - March 29 at 7:38 PM
Viking Therapeutics Climbs After Fatty Liver Disease ResultsViking Therapeutics Climbs After Fatty Liver Disease Results
www.bloomberg.com - March 27 at 7:47 PM
Analysts Are Mostly Positive on Viking Therapeutics in MarchAnalysts Are Mostly Positive on Viking Therapeutics in March
finance.yahoo.com - March 27 at 7:47 PM
Viking Therapeutics up 7% premarket on positive VK2809 dataViking Therapeutics up 7% premarket on positive VK2809 data
seekingalpha.com - March 27 at 8:28 AM
Viking Therapeutics Inc.Viking Therapeutics Inc.
www.barrons.com - March 21 at 7:48 PM
Edited Transcript of VKTX earnings conference call or presentation 13-Mar-19 8:30pm GMTEdited Transcript of VKTX earnings conference call or presentation 13-Mar-19 8:30pm GMT
finance.yahoo.com - March 15 at 8:31 AM
VKTX: Phase 2b Trial for VK2809 to Initiate 2H19…VKTX: Phase 2b Trial for VK2809 to Initiate 2H19…
finance.yahoo.com - March 14 at 7:19 PM
Shareholders Are Raving About How The Viking Therapeutics (NASDAQ:VKTX) Share Price Increased 346%Shareholders Are Raving About How The Viking Therapeutics (NASDAQ:VKTX) Share Price Increased 346%
finance.yahoo.com - March 13 at 7:06 PM
Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate UpdateViking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - March 13 at 7:06 PM
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2018 on March 13, 2019Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2018 on March 13, 2019
finance.yahoo.com - March 6 at 8:28 AM
CymaBay And Viking Therapeutics In NASH, And The Market AssessmentCymaBay And Viking Therapeutics In NASH, And The Market Assessment
seekingalpha.com - March 1 at 8:41 AM
Viking Therapeutics to Participate in Upcoming Investor Conferences and EventsViking Therapeutics to Participate in Upcoming Investor Conferences and Events
finance.yahoo.com - February 26 at 8:23 AM
Healthcare Companies Investors are WatchingHealthcare Companies Investors are Watching
finance.yahoo.com - February 21 at 8:29 AM
Should You Buy Viking Therapeutics After Gilead Drug Failure?Should You Buy Viking Therapeutics After Gilead Drug Failure?
investorplace.com - February 14 at 10:18 AM
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel